Inappropriate censoring in Kaplan-Meier analyses

[...]with the rate of progression or death for each interval calculated, a product–limit estimator generates a progression or mortality risk (a hazard rate). [...]censoring must be non-informative, infrequent, and balanced between treatment groups. [...]discussion of results must acknowledge the limitations of data heavily burdened by censoring that is possibly or likely to be informative.